Latest filing published 11 May 2016 for BioCardia, Inc., €5.6M.
Insider track record
Closed purchases
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +500.0%Entry US$129.60 · Close at T+365 US$777.60
- +37.5%Entry US$129.60 · Close at T+365 US$178.20
- +42.9%Entry US$113.40 · Close at T+365 US$162.00
- +66.7%Entry US$97.20 · Close at T+365 US$162.00
- +50.0%Entry US$97.20 · Close at T+365 US$145.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Andrew A. Brooks: trading record in brief
Andrew A. Brooks discloses dealings in BioCardia, Inc. to SEC (Form 4). Between 12 January 2009 and 10 May 2016, the trades on record add up to 13 filings.
The open-market side counts 12 purchases for €126k alongside 1 sale for €5.6M. Netting one side against the other leaves €5.5M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2016, the count stands at 3 purchases and 1 sale.
The median purchase comes to €1,630. For 11 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +50.0%. This is a record of the past, not a forecast.
The latest filing, published on 11 May 2016, reports an open-market sale of €5.6M in BioCardia, Inc. The latest purchase dates back some time: it was published 3,882 days ago, on 24 March 2016. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew A. Brooks
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 63,560,031 shares@ US$0.10100.0% of flowCommon StockSEC:0001209191-16-119173:0
- 680,034 shares@ US$0.067Common StockSEC:0001209191-16-110499:0Canonical exit: 31 Mar 2013 (T+90)
- 10,000 shares@ US$0.080.0% of flowCommon StockSEC:0001209191-16-110500:0Canonical exit: 19 Nov 2015 (T+90)
- 16,500 shares@ US$0.0680.0% of flowCommon StockSEC:0001209191-16-110500:1Canonical exit: 8 Mar 2016 (T+90)
- 205,808 shares@ US$0.077Common StockSEC:0001209191-13-040670:0Canonical exit: 10 Nov 2013 (T+90)
- 9,000 shares@ US$0.06Common StockSEC:0001209191-13-003397:0Canonical exit: 14 Apr 2013 (T+90)
- 60,000 shares@ US$0.06Common StockSEC:0001209191-13-002975:0Canonical exit: 10 Apr 2013 (T+90)
- 700,000 shares@ US$0.06Common StockSEC:0001209191-13-002975:1Canonical exit: 11 Apr 2013 (T+90)
- 49,000 shares@ US$0.06Common StockSEC:0001209191-13-000507:0Canonical exit: 26 Mar 2013 (T+90)
- 6,000 shares@ US$0.058Common StockSEC:0001209191-13-000507:1Canonical exit: 28 Mar 2013 (T+90)
- 674,205 shares@ US$0.0649Common StockSEC:0001209191-13-000507:2Canonical exit: 31 Mar 2013 (T+90)
- 500 shares@ US$1.01Common StockSEC:0001442510-09-000001:0Canonical exit: 20 Apr 2009 (T+90)
- 500 shares@ US$1.01Common StockSEC:0001136261-09-000017:0Canonical exit: 12 Apr 2009 (T+90)
13 of 13 declarations
